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Abstract
Background: Bryophyllum pinnatum (Lank.) Oken (Crassulaceae) is a perennial succulent herb widely used in
traditional medicine to treat many ailments. Its wide range of uses in folk medicine justifies its being called “life
plant“ or “resurrection plant“, prompting researchers’ interest. We describe here the isolation and structure
elucidation of antimicrobial and/or antioxidant components from the EtOAc extract of B. pinnatum.
Results: The methanol extract displayed both antimicrobial activities with minimum inhibitory concentration (MIC)
values ranging from 32 to 512 μg/ml and antioxidant property with an IC50 value of 52.48 μg/ml. Its partition
enhanced the antimicrobial activity in EtOAc extract (MIC = 16-128 μg/ml) and reduced it in hexane extract (MIC =
256-1024 μg/ml). In addition, this process reduced the antioxidant activity in EtOAc and hexane extracts with IC50
values of 78.11 and 90.04 μg/ml respectively. Fractionation of EtOAc extract gave seven kaempferol rhamnosides,
including; kaempferitrin (1), kaempferol 3-O-a-L-(2-acetyl)rhamnopyranoside-7-O-a-L-rhamnopyranoside (2),
kaempferol 3-O-a-L-(3-acetyl)rhamnopyranoside-7-O-a-L-rhamnopyranoside (3), kaempferol 3-O-a-L-(4-acetyl)
rhamnopyranoside-7-O-a-L-rhamnopyranoside (4), kaempferol 3-O-a-D- glucopyranoside-7-O-a-L-
rhamnopyranoside (5), afzelin (6) and a-rhamnoisorobin (7). All these compounds, except 6 were isolated from this
plant for the first time. Compound 7 was the most active, with MIC values ranging from 1 to 2 μg/ml and its
antioxidant activity (IC50 = 0.71 μg/ml) was higher than that of the reference drug (IC50 = 0.96 μg/ml).
Conclusion: These findings demonstrate that Bryophyllum pinnatum and some of its isolated compounds have
interesting antimicrobial and antioxidant properties, and therefore confirming the traditional use of B. pinnatum in
the treatment of infectious and free radical damages.
Keywords: Bryophyllum pinnatum, Crassulaceae, Kaempferol rhamnosides, Antimicrobial, Antioxidant, Minimum
inhibitory concentration
Background
Bryophyllum pinnatum (Lank.) Oken, syn. B. calucinum
or Kalanchoe pinnata (Crassulaceae) is a perennial suc-
culent herb which grows in Africa and Asia [1]. An eth-
nobotanical survey of plants used in the treatment of
infectious diseases in Mbouda subdivision (Cameroon)
indicated that B. pinnatum was one of the most used
medicinal plants in the area. Therefore information
collected directly from traditional healers and herbal
sellers in this area indicated that, leaves or the whole
plant are used as analgesic and to treat blennorrhoea,
syphilis, jaundice, candidiasis, dysmenorrhoea, external
ulcers, burns and convulsions. B. pinnatum is also used
elsewhere for treatment of ear infections, cough and
dysentery [2]. This wide range of traditional uses justi-
fies its being called “life plant“, “resurrection plant“ or
“goodluck“ [3,4]. Previous phytochemical studies revealed
the presence of terpenoids [1], cytotoxic bufadienolides
[5] and antileishmanial flavonoids [6] in this plant. In
addition, 60% methanolic extract of leaves of B.
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pinnatum have shown antimicrobial activity [2], while
water extracts have shown anti-ulcer, antinociceptive,
anti-inflammatory, antidiabetic, neurosedative and mus-
cle relaxant activities [3,4,7], and ethanolic extract have
exhibited hepatoprotective activity [8]. In the course of
our search for bioactive components from Cameroonian
medicinal plants, phytochemical and biological investiga-
tions of B. pinnatum were carried out. We describe here
the isolation and structure elucidation, antimicrobial
and antioxidant properties of seven kaempferol rhamno-
sides (1-7) from B. pinnatum which may account for
some of the ethnomedicinal uses of leaves or the whole
plant.
Results
Chemical analysis
The whole plant of B pinnatum was dried between 36-
38°C during two weeks. This raw material (1.50 Kg) was
extracted with MeOH and the MeOH extract was parti-
tioned with hexane and ethyl acetate. The resulting
extracts underwent antimicrobial (antibacterial and anti-
fungal) and antioxidant assays revealing MICs values
from 16-1024 μg/ml and IC50 values from 52.48-90.04
μg/ml. The antimicrobial activity was found to be more
concentrated in EtOAc extract and diluted in hexane
extract. The EtOAc extract was then subjected to col-
umn chromatography to yield seven kaempferol deriva-
tives: kaempferitrin (435.10 mg) (1) [9], kaempferol 3-O-
a-L-(2-acetyl)rhamnopyranoside-7-O-a-L-rhamnopyra-
noside (10.10 mg) (2) [10], kaempferol 3-O-a-L-(3-
acetyl)rhamnopyranoside-7-O-a-L-rhamnopyranoside
(38.40 mg) (3) [10], kaempferol 3-O-a-L-(4-acetyl)rham-
nopyranoside-7-O-a-L-rhamnopyranoside (25.10 mg) (4)
[11], kaempferol 3-O-a-D- glucopyranoside-7-O- a-L-
rhamnopyranoside (40,90 mg) (5) [12], afzelin (34.60
mg) (6) [9] and a-rhamnoisorobin (5.0 mg) (7) [9] (Fig-
ure 1). These compounds except afzelin (6) were iso-
lated for the first time in this species.
Antimicrobial activity
The MeOH, EtOAc and hexane extracts as well as iso-
lated compounds were tested for their antimicrobial
activity and the results obtained are presented in Table
1. The crude extracts have shown both antibacterial and
antifungal activities, on the set of germs tested with
MIC values ranging from 16 to 1024 μg/ml. The EtOAc
extract was more active (MIC = 16-128 μg/ml) than the
MeOH extract (MIC = 32-512 μg/ml) and the hexane
extract (MIC = 128-1024 μg/ml), meaning that the
active principles might be more concentrated in the
EtOAc extract. Compound 7 isolated from the EtOAc
extract was more active (MIC = 1-2 μg/ml) than all the
other tested compounds. This is followed in decreasing
order by compounds 5, 6, 1, 3 and 4. The antimicrobial
activity of compound 7 was in some cases equal to
those of the positive controls (ciprofloxacin and nysta-
tin). Nevertheless, the antibacterial activity of this com-
pound (MIC = 1 μg/ml) was higher than that of the
positive control ciprofloxacin (MIC = 2 μg/ml) against
Pseudomonas aeruginosa.
 
R1= Rha, R2= Rha: kaempferitrin, 1 
R1= Rha-2OAc, R2= Rha: kaempferol 3-O-α-L-(2-acetyl)rhamnopyranoside-7-O-α-L-rhamnopyranoside, 2 
R1= Rha-3OAc, R2= Rha: kaempferol 3-O-α-L-(3-acetyl)rhamnopyranoside-7-O-α-L-rhamnopyranoside, 3 
R1= Rha-4OAc, R2 = Rha: kaempferol 3-O-α-L-(4-acetyl)rhamnopyranoside-7-O-α-L-rhamnopyranoside, 4
R1 = Glc, R2 = Rha: kaempferol 3-O-α-D- glucopyranoside-7-O- α-L-rhamnopyranoside, 5  
R1= Rha, R2= H: afzelin, 6  
R1= H, R2= Rha: α-rhamnoisorobin, 7 
Figure 1 Chemical structures of compounds isolated from B. pinnatum.
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Antioxidant activity
The results of the antioxidant activities of the MeOH,
EtOAc and hexane extracts as well as their isolated
compounds are presented in Table 2. It appeared that
the MeOH extract (IC50 = 52.48 μg/ml) was more active
than the EtOAc extract (IC50 = 78.11 μg/ml) and hexane
extract (IC50 = 90.04 μg/ml). The antioxidant activity of
compound 7 (IC50 = 0.71 μg/ml) was higher than that
of the reference drug (IC50 = 0.96 μg/ml). No biological
test was done with compound 2 since it was obtained as
a mixture with compound 3.
Discussion
The findings of the present study showed differences
between the antimicrobial activities of crude MeOH
extract and extracts from partition. This suggests that B.
pinnatum contains several antifungal and antibacterial
principles with different polarities as shown by the phy-
tochemical study. The partition of the MeOH extract
enhanced its antimicrobial activity in EtOAc fraction,
and reduced that of hexane fraction. This indicates that
the active principles might be more concentrated in
EtOAc fraction and more diluted in hexane fraction. All
Table 1 Antimicrobial activity (in μg/ml) of crude extracts of B. pinnatu m and isolates from EtOAc extract
Test samples (extracts and
isolates 1-7)
Inhibition
parameters
Staphylococcus
aureus
Pseudomonas
aeruginosa
Salmonella
typhi
Candida
albicans
Candida
parapsilosis
Cryptococcus
neoformans
MeOH extract MIC 256 512 64 64 32 32
MMC 256 512 128 64 32 64
MMC/MIC 1 1 2 1 1 2
EtOAc extract MIC 64 128 16 32 16 16
MMC 64 256 16 32 32 16
MMC/MIC 1 2 1 1 2 1
n-hexane extract MIC 512 1024 256 256 128 1024
MMC 512 1024 256 256 128 1024
MMC/MIC 1 1 1 1 1 1
1 MIC 32 32 32 32 16 16
MMC 32 64 32 64 16 16
MMC/MIC 1 2 1 2 1 1
4 MIC 64 128 32 64 32 32
MMC 64 128 32 128 32 32
MMC/MIC 1 1 1 2 1 1
6 MIC 8 16 2 16 4 4
MMC 8 16 2 32 4 4
MMC/MIC 1 1 1 2 1 1
5 MIC 4 4 1 8 2 2
MMC 8 4 2 8 2 4
MMC/MIC 2 1 2 1 1 2
7 MIC 2 1 1 1 2 2
MMC 2 2 1 1 2 2
MMC/MIC 1 2 1 1 1 1
3 MIC 256 128 64 32 16 16
MMC 256 128 64 32 32 16
MMC/MIC 1 1 1 1 2 1
Ciprofloxacin MIC 2 2 0.5 / / /
MMC 2 2 1 / / /
MMC/MIC 1 1 2 / / /
Nystatin MIC / / / 2 1 0.5
MMC / / / 2 1 0.5
MMC/MIC / / / 1 1 1
/: not determined
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the isolated compounds showed antimicrobial activities
on at least one microorganism. Such a finding supports
the traditional use of this plant in the treatment of
infectious diseases. The result of the antimicrobial activ-
ity of MeOH extract from the whole plant of B. Pinna-
tum corroborates that of Akinpelu [2].
The antimicrobial activities varied with the bacterial and
fungal species. These variations may be due to genetic dif-
ferences between the microorganisms. A keen look at the
results of MIC and minimum microbicidal concentration
(MMC) (Table 1), showed that the MIC values obtained
are in most cases equal to the MMC values on the corre-
sponding (sensitive) microorganisms, confirming the
microbicidal effects of the tried samples [13]. This is inter-
esting in view of the perspective of developing new anti-
bacterial drugs from natural products.
The antimicrobial activity was more concentrated in
EtOAc fraction. In contrast, the antioxidant activity is
more concentrated in MeOH extract. This indicates that
partition of the crude extract did not enhance the anti-
oxidant activity of its fractions. Flavonoid compounds
such as compounds 1-7 are known to be potential anti-
oxidant due to their ability to scavenge free radicals and
active oxygen species such as singlet oxygen, superoxide
anion radical and hydroxyl radicals [14,15]. The antimi-
crobial activity of flavonoids (compounds 1-7) might be
due to their ability to complex with bacteria cell wall
and therefore, inhibiting the microbial growth [16]. The
presence of these compounds could explain the antioxi-
dant activity found in the crude extract.
Compounds 1, 3-7 displayed both antibacterial and
antifungal activities. However, this is the first report
concerning the antimicrobial and antioxidant activities
of these compounds.
The overall results of this study can be considered as
very promising in the perspective of new drugs discovery
from plant sources, when considering the medical impor-
tance of tested microorganisms. Staphylococcus aureus is
a major cause of community and hospital-associated
infection with an estimated mortality of around 7-10%
[17]. About 77% of immune-deficient patients’ death is
attributed to microscopic fungi, such as Candida species
and Cryptococcus neoformans [18]. Also, Candida albi-
cans has been reported to account for 50-70% cases of
invasive candidiasis [19]. Alarmingly, the incidence of
nosocomial candidemia has risen sharply in the last dec-
ade [20]. All this has resulted in severe consequences
including increased cost of medicines and mortality of
patients. Typhoid fever caused by Salmonella typhi con-
tinues to be a serious public health problem in develop-
ing countries in general and in Sub-Saharan Africa in
particular [17]. Generally, these pathogens were found to
be sensitive to extracts and isolated compounds.
Conclusion
These findings demonstrated that methanol and ethyl
acetate extracts of B. pinnatum and the isolated com-
pounds exhibited interesting antimicrobial and antioxi-
dant properties, justifying the traditional uses of the
plant in the treatment of infectious diseases and free
radical damages. However, further pharmacological and
toxicological studies need to be done in order to con-
firm or infirm this hypothesis.
Methods
Plant material
The whole plant of B. pinnatum was collected in
Mbouda subdivision, West region of Cameroon in
August 2009. It was identified by Mr. Nana at the
National Herbarium, Yaoundé where a voucher speci-
men 33394 HNC describing the plant is deposited.
Extraction and isolation
Dried and ground whole plant of B. pinnatum [1] (1.50 Kg)
was extracted by percolation with methanol (10 L) at room
temperature. Filtration and evaporation of solvent under
reduced pressure gave a brown residue (148 g). This extract
was successively partitioned with n-hexane and ethyl acet-
ate to yield 38.03 and 34.03 g of extracts respectively [21].
All extracts were kept in the refrigerator at around 4°C.
The EtOAc extract (34.03 g) was subjected to silica gel
column chromatography (6 × 30 cm, 300 g) eluted with
a gradient system of hexane-EtOAc-MeOH gradients.
182 fractions of 200 mL each were collected and com-
bined according to TLC profile into nine main fractions:
A (fractions 1-45), B (fractions 46-70), C (fractions 71-
92), D (fractions 93-109), E (fractions 110-129), F (frac-
tions 130-140), G (fractions 141-154), H (fractions 155-
170), I (fractions 171-182). G (8.91 g) was loaded on a
silica gel column eluted with CH2Cl2-MeOH gradients
Table 2 Inhibition concentrations of the test samples
scavenging 50% of DPPH radical (IC50)
Test samples (extracts and isolates 1-7 from EtOAc
extract)
IC50 (μg/ml)
MeOH extract 52.48 ± 0.19a
EtOAc extract 78.11 ± 0.61b
n-hexane extract 90.04 ± 1.26c
1 8.73 ± 0.51d
4 273.81 ± 0.43e
3 487.99 ± 0.81f
6 6.44 ± 0.74g
5 2.28 ± 0.12h
7 0.71 ± 0.09i
Vitamin C 0.96 ± 0.14j
Values are expressed as mean ± SD. In the same column, values affected by
the different superscript letters (a-j) are significantly different p < 0.05.
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and 200 fractions of 13 ml each were collected. Subfrac-
tions 114-140 obtained with CH2Cl2-MeOH (87.5-12.5,
200 mL; 85-15, 200 mL) were again subjected to silica
gel column chromatography eluted with a gradient sys-
tem of EtOAc-MeOH-H2O to yield 50 fractions of 13
mL each. Subfractions 8-11 obtained with EtOAc-
MeOH-H2O (98-02-0.1) were purified on a sephadex
LH-20 column eluted with MeOH to give afzelin (6) as
yellow crystal; and a-rhamnoisorobin (7) as amorphous
yellowish pate. Subfractions 17-32 obtained with EtOAc-
MeOH-H2O (98-02-0.1 and 96-04-0.1) were loaded on
vaccum RP-18 column eluted with H2O-MeOH gradi-
ents (60-40 to 0-100) and fractions obtained were
loaded on preparative RP-TLC to yield kaempferol 3-O-
a-L-(3-acetyl)rhamnopyranoside-7-O-a-L-rhamnopyra-
noside (3), kaempferol 3-O-a-L-(4-acetyl)rhamnopyra-
noside-7-O-a-L-rhamnopyranoside (4) and a mixture of
kaempferol 3-O-a-L-(2-acetyl)rhamnopyranoside-7-O-a-
L-rhamnopyranoside (2) and compound 3. Subfractions
141-155 from G, obtained with CH2Cl2-MeOH (81.5-
17.5; 200 mL) were purified on a sephadex LH-20 col-
umn eluted with MeOH to yield yellow crystal of
kaempferitrin (1). I (821 mg) was loaded on vaccum RP-
column eluted with H2O-MeOH gradients (60-40 to 0-
100) and 67 fractions of 15 mL each were collected.
Subfractions 30-45 obtained with H2O-MeOH (85-15)
were again subjected to RP-column eluted with H2O-
MeOH (60-0 to 40-60) and fractions were purified on
MeOH sephadex column and an isocratic H2O-MeOH
(80-20) RP-column to yield 3-O-a-D-glucopyranoside-7-
O-a-L-rhamnopyranoside (5). The chemical structures
of the isolated compounds are shown in Figure 1.
General procedure
NMR spectra were measured on Bruker Avance DRX 500
and Brucker Ultrashield Plus 600 spectrometers at 500
and 600 MHz for 1H, and 125 and 150 MHz for 13 C
NMR, with TMS as internal standard; chemical shifts are
given in δ values (ppm). MS analyses were performed
using a QTOF Premier (Waters, Milford, MA) equipped
with a nanoelectrospray ionization source. The instru-
ment was operated in positive ion mode, performing full-
scan analysis over the m/z range 50-1990 at 1 spectra/s.
Column chromatography was run on Merck silica gel 60
(0.063-0.200 mm), Lichoprep RP-18 (40-63 μm) and
Sephadex LH-20 while TLC was carried out on silica gel
GF254 pre-coated plates with detection accomplished by
visualizing with a UV lamp at 254 and 365 nm, followed
by spraying with vanillin and then heating at 100°C.
Biological tests
Antimicrobial activity
Microorganisms The microorganisms used in this study
consisted of three bacteria (Staphylococcus aureus
ATCC25922, Pseudomonas aeruginosa ATCC27853, Sal-
monella typhi ATCC6539) and two Candida species
(Candida albicans ATCC9002 and Candida parapsilosis
ATCC22019), all of which are reference strains obtained
from the American Type Culture Collection. Also,
included was one strain of Cryptococcus neoformans
IP95026 obtained from the Pasteur Institute (IP, Paris-
France). The bacterial and yeast strains were grown at
35°C and maintained on nutrient agar (NA, Conda,
Madrid, Spain) and Sabouraud Dextrose Agar (SDA,
Conda) slants, respectively.
Determination of Minimum Inhibitory Concentration
(MIC) and Minimum Microbicidal Concentration
(MMC) MICs were determined by broth micro dilution
method as described by Nyaa et al. in 2009 with slight
modifications [22]. The test samples were first of all dis-
solved in dimethylsulfoxide (DMSO). The solution
obtained was then added to Mueller Hinton Broth
(MHB) for bacteria or Sabouraud Dextrose Broth (SDB)
for yeasts to give a final concentration of 2048 μg/ml.
This was serially diluted two fold to obtain concentra-
tion ranges of 0.50 to 2048 μg/ml. Each concentration
(100 μl) was added in each well (96-wells microplate)
containing 95 μl of MHB or SDB and 5 μl of inoculum
for final concentrations varying from 0.25 to 1024 μg/
ml. The inoculum was standardized at 1.50 × 106 CFU/
ml by adjusting the optical density to 0.10 at 600 nm
JENWAY 6105 UV/Vis spectrophotometer. The final
concentration of DMSO in each well was less than 1%
(preliminary analyses with 1% (v/v) DMSO do not inhi-
bit the growth of the test organisms). The negative con-
trol well consisted of 195 μl of appropriate medium
(MHB for bacteria and SDB for yeasts) and 5 μl of the
standard inoculum. The plates were covered with the
sterile lid, then agitated to mix the contents of the wells
using a plate shaker and incubated at 35°C for 24 h (for
bacteria) or for 48 h (for yeasts). The assay was repeated
thrice. The MICs of samples were determined by adding
50 μl of a 0.2 mg/ml p-iodonitrotetrazolium violet solu-
tion followed by incubation at 35°C for 30 min. Viable
micro-organisms reduced the yellow dye to a pink color.
MICs were defined as the lowest sample concentrations
that prevented this change in color indicating a com-
plete inhibition of microbial growth.
For the determination of MMCs, a portion of liquid (5
μl) from each well that showed no growth of microor-
ganism was placed on Mueller Hinton Agar or Sabour-
aud Dextrose Agar and incubated at 35°C for 24 h (for
bacteria) or 35°C for 48 h (for yeasts). The lowest con-
centrations that yielded no growth after this sub-cultur-
ing were taken as the MMCs [22]. Ciprofloxacin
(Sigma-Aldrich, Steinheim, Germany) and nystatin
(Merck, Darmstadt, Germany) for bacteria and yeasts,
respectively, were used as positive controls.
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Antioxidant assay
The antioxidant activities of methanol, EtOAc and hex-
ane extracts, and isolated compounds were evaluated by
2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) radical
scavenging method as described by Mensor et al. in
2001 with slight modifications [23]. The test samples,
initially dissolved in DMSO (SIGMA) were mixed with a
20 mg/l of 2,2-diphenyl-1-picryl-hydrazyl-hydrate
(DPPH) methanol solution, to give final concentrations
of 10, 50, 100, 500 and 1000 μg/ml. After 30 min at
room temperature, the absorbance values were mea-
sured at 517 nm and converted into percentage of anti-
oxidant activity as follows:
% Inhibition = (Absorbance of control - Absorbance
of test sample) × 100/Absorbance of control
L-ascorbic acid was used as a standard control. The
inhibition ratio was converted in probits. The probit
values were plotted against the logarithmic values of
concentrations of the test samples and a linear regres-
sion curve was established in order to determined the
IC50 (μg/ml) values, which is the amount of sample
necessary to decrease by 50% the absorbance of DPPH.
All the analyses were carried out in triplicate and the
results were expressed as the mean ± standard deviation
(SD) and compared using Waller-Duncan test. A value
of p < 0.05 was considered statistically significant.
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